Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

RIP1-driven autoinflammation targets IL-1α independently of inflammasomes and RIP3

Nature volume 498, pages 224–227 (2013)Cite this article

Subjects

Abstract

The protein-tyrosine phosphatase SHP-1 has critical roles in immune signalling, but how mutations in SHP-1 cause inflammatory disease in humans remains poorly defined1. Mice homozygous for the Tyr208Asn amino acid substitution in the carboxy terminus of SHP-1 (referred to as Ptpn6spin mice) spontaneously develop a severe inflammatory syndrome that resembles neutrophilic dermatosis in humans and is characterized by persistent footpad swelling and suppurative inflammation2,3. Here we report that receptor-interacting protein 1 (RIP1)-regulated interleukin (IL)-1α production by haematopoietic cells critically mediates chronic inflammatory disease in Ptpn6spin mice, whereas inflammasome signalling and IL-1β-mediated events are dispensable. IL-1α was also crucial for exacerbated inflammatory responses and unremitting tissue damage upon footpad microabrasion of Ptpn6spin mice. Notably, pharmacological and genetic blockade of the kinase RIP1 protected against wound-induced inflammation and tissue damage in Ptpn6spin mice, whereas RIP3 deletion failed to do so. Moreover, RIP1-mediated inflammatory cytokine production was attenuated by NF-κB and ERK inhibition. Together, our results indicate that wound-induced tissue damage and chronic inflammation in Ptpn6spin mice are critically dependent on RIP1-mediated IL-1α production, whereas inflammasome signalling and RIP3-mediated necroptosis are dispensable. Thus, we have unravelled a novel inflammatory circuit in which RIP1-mediated IL-1α secretion in response to deregulated SHP-1 activity triggers an inflammatory destructive disease that proceeds independently of inflammasomes and programmed necrosis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Ptpn6spin mice develop spontaneous footpad inflammation.
Figure 2: Deletion of IL-1α limits Ptpn6spin-mediated disease.
Figure 3: Exacerbated wound-healing responses contribute to disease in Ptpn6spin mice.
Figure 4: RIP1 regulates Ptpn6spin-mediated disease through the control of proinflammatory signalling and Il1a expression and not via RIP3-induced necroptosis.

Similar content being viewed by others

References

  1. Pao, L. I., Badour, K., Siminovitch, K. A. & Neel, B. G. Nonreceptor protein-tyrosine phosphatases in immune cell signaling. Annu. Rev. Immunol. 25, 473–523 (2007)

    Article  CAS  Google Scholar 

  2. Nesterovitch, A. B. et al. Spontaneous insertion of a b2 element in the ptpn6 gene drives a systemic autoinflammatory disease in mice resembling neutrophilic dermatosis in humans. Am. J. Pathol. 178, 1701–1714 (2011)

    Article  CAS  Google Scholar 

  3. Croker, B. A. et al. Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger. Proc. Natl Acad. Sci. USA 105, 15028–15033 (2008)

    Article  ADS  CAS  Google Scholar 

  4. Cao, H. & Hegele, R. A. Identification of polymorphisms in the human SHP1 gene. J. Hum. Genet. 47, 445–447 (2002)

    Article  CAS  Google Scholar 

  5. Christophi, G. P. et al. SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients. Lab. Invest. 88, 243–255 (2008)

    Article  CAS  Google Scholar 

  6. Green, M. C. & Shultz, L. D. Motheaten, an immunodeficient mutant of the mouse. I. Genetics and pathology. J. Hered. 66, 250–258 (1975)

    Article  CAS  Google Scholar 

  7. Shultz, L. D., Coman, D. R., Bailey, C. L., Beamer, W. G. & Sidman, C. L. “Viable motheaten,” a new allele at the motheaten locus. I. Pathology. Am. J. Pathol. 116, 179–192 (1984)

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Shultz, L. D. et al. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73, 1445–1454 (1993)

    Article  CAS  Google Scholar 

  9. Tsui, H. W., Siminovitch, K. A., de Souza, L. & Tsui, F. W. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nature Genet. 4, 124–129 (1993)

    Article  CAS  Google Scholar 

  10. Lorenz, U. SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels. Immunol. Rev. 228, 342–359 (2009)

    Article  Google Scholar 

  11. Lukens, J. R., Dixit, V. D. & Kanneganti, T. D. Inflammasome activation in obesity-related inflammatory diseases and autoimmunity. Discov. Med. 12, 65–74 (2011)

    PubMed  PubMed Central  Google Scholar 

  12. Tschopp, J. & Schroder, K. NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production? Nature Rev. Immunol. 10, 210–215 (2010)

    Article  CAS  Google Scholar 

  13. Chen, C. J. et al. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nature Med. 13, 851–856 (2007)

    Article  CAS  Google Scholar 

  14. Cohen, I. et al. Differential release of chromatin-bound IL-1α discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation. Proc. Natl Acad. Sci. USA 107, 2574–2579 (2010)

    Article  ADS  CAS  Google Scholar 

  15. Rider, P. et al. IL-1α and IL-1β recruit different myeloid cells and promote different stages of sterile inflammation. J. Immunol. 187, 4835–4843 (2011)

    Article  CAS  Google Scholar 

  16. Kranich, J., Maslowski, K. M. & Mackay, C. R. Commensal flora and the regulation of inflammatory and autoimmune responses. Semin. Immunol. 23, 139–145 (2011)

    Article  CAS  Google Scholar 

  17. Henao-Mejia, J. et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179–185 (2012)

    Article  ADS  CAS  Google Scholar 

  18. Kubes, P. & Mehal, W. Z. Sterile inflammation in the liver. Gastroenterology 143, 1158–1172 (2012)

    Article  CAS  Google Scholar 

  19. Chen, G. Y. & Nunez, G. Sterile inflammation: sensing and reacting to damage. Nature Rev. Immunol. 10, 826–837 (2010)

    Article  CAS  Google Scholar 

  20. Vandenabeele, P., Declercq, W., Van Herreweghe, F. & Vanden Berghe, T. The role of the kinases RIP1 and RIP3 in TNF-induced necrosis. Sci. Signal. 3, re4 (2010)

    Article  Google Scholar 

  21. Kelliher, M. A. et al. The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity 8, 297–303 (1998)

    Article  CAS  Google Scholar 

  22. Takahashi, N. et al. Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis. 3, e437 (2012)

    Article  CAS  Google Scholar 

  23. Amulic, B., Cazalet, C., Hayes, G. L., Metzler, K. D. & Zychlinsky, A. Neutrophil function: from mechanisms to disease. Annu. Rev. Immunol. 30, 459–489 (2012)

    Article  CAS  Google Scholar 

  24. Kanneganti, T. D. et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 440, 233–236 (2006)

    Article  ADS  CAS  Google Scholar 

  25. Shornick, L. P. et al. Mice deficient in IL-1β manifest impaired contact hypersensitivity to trinitrochlorobenzone. J. Exp. Med. 183, 1427–1436 (1996)

    Article  CAS  Google Scholar 

  26. Matsuki, T., Nakae, S., Sudo, K., Horai, R. & Iwakura, Y. Abnormal T cell activation caused by the imbalance of the IL-1/IL-1R antagonist system is responsible for the development of experimental autoimmune encephalomyelitis. Int. Immunol. 18, 399–407 (2006)

    Article  CAS  Google Scholar 

  27. Newton, K., Sun, X. & Dixit, V. M. Kinase RIP3 is dispensable for normal NF-κBs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4. Mol. Cell. Biol. 24, 1464–1469 (2004)

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank B. A. Buetler, V. M. Dixit and D. R. Green for supply of mutant mice. We thank R. Weinlich for helpful discussions. We thank M. Johnson in the St Jude Small Animal Imaging Center for helping to evaluate embryonic development in fetal liver transplantation studies. M.L. is supported by European Union Marie-Curie grant 256432, ERC grant 281600, and grants G030212N, 1.2.201.10.N.00 and 1.5.122.11.N.00 from the Fund for Scientific Research-Flanders. This work was supported by grants from the National Institutes of Health (grants AR056296, CA163507 and AI101935) and the American Lebanese Syrian Associated Charities (ALSAC) to T.-D.K.

Author information

Author notes

  1. Mohamed Lamkanfi and Thirumala-Devi Kanneganti: These authors contributed equally to this work.

Authors and Affiliations

  1. Department of Immunology, St Jude Children’s Research Hospital, Memphis, 38105, Tennessee, USA

    John R. Lukens, Gordon R. Johnson & Thirumala-Devi Kanneganti

  2. Animal Resources Center and the Veterinary Pathology Core, St Jude Children’s Research Hospital, Memphis, 38105, Tennessee, USA

    Peter Vogel

  3. Department of Cancer Biology, University of Massachusetts Medical School, Worcester, 01605, Massachusetts, USA

    Michelle A. Kelliher

  4. Center for Experimental Medicine, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan,

    Yoichiro Iwakura

  5. Department of Medical Protein Research, VIB, B-9000 Ghent, Belgium,

    Mohamed Lamkanfi

  6. Department of Biochemistry, Ghent University, B-9000 Ghent, Belgium,

    Mohamed Lamkanfi

Authors
  1. John R. Lukens
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter Vogel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gordon R. Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michelle A. Kelliher
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yoichiro Iwakura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mohamed Lamkanfi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Thirumala-Devi Kanneganti
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

J.R.L., M.L. and T.-D.K. designed the study; J.R.L. performed experiments and G.R.J. provided technical assistance; J.R.L., M.L. and T.-D.K. analysed data and wrote the manuscript; M.A.K. and Y.I. provided genetic tools; P.V. performed and analysed the histopathology data; T.-D.K. oversaw the project.

Corresponding author

Correspondence to Thirumala-Devi Kanneganti.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Information

This file contains Supplementary Figures 1-19. (PDF 2043 kb)

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lukens, J., Vogel, P., Johnson, G. et al. RIP1-driven autoinflammation targets IL-1α independently of inflammasomes and RIP3. Nature 498, 224–227 (2013). https://doi.org/10.1038/nature12174

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature12174

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing